The role of norepinephrine in epilepsy: from the bench to the bedside
暂无分享,去创建一个
Filippo S. Giorgi | Luigi Murri | L. Murri | F. Biagioni | F. Fornai | F. Giorgi | Chiara Pizzanelli | Francesca Biagioni | Francesco Fornai | C. Pizzanelli
[1] E. Wong,et al. The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. , 2006, CNS drug reviews.
[2] Gary Aston-Jones,et al. CHAPTER 11 – Locus Coeruleus, A5 and A7 Noradrenergic Cell Groups , 2004 .
[3] G. Tononi,et al. Extensive and Divergent Effects of Sleep and Wakefulness on Brain Gene Expression , 2004, Neuron.
[4] C. Elger,et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants , 2003, Epilepsy & Behavior.
[5] K. Matthews,et al. Vagus nerve stimulation and refractory depression , 2003, British Journal of Psychiatry.
[6] L. Murri,et al. A damage to locus coeruleus neurons converts sporadic seizures into self‐sustaining limbic status epilepticus , 2003, The European journal of neuroscience.
[7] Lippincott Williams Wilkins,et al. Practice Parameter: Temporal lobe and localized neocortical resections for epilepsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology, in Association with the American Epilepsy Society and the American Association of Neurological Surgeons , 2003, Neurology.
[8] H. Sackeim,et al. Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders. , 2003, The international journal of neuropsychopharmacology.
[9] F. Dudek,et al. Effects of Fluoxetine and TFMPP on Spontaneous Seizures in Rats with Pilocarpine‐induced Epilepsy , 2002, Epilepsia.
[10] H. Lüders,et al. Systemic Overexpression of the α1B‐Adrenergic Receptor in Mice: An Animal Model of Epilepsy , 2002 .
[11] Steven C Schachter,et al. Vagus nerve stimulation therapy summary: Five years after FDA approval , 2002, Neurology.
[12] M. Min,et al. Change in bi‐directional plasticity at CA1 synapses in hippocampal slices taken from 6‐hydroxydopamine‐treated rats: the role of endogenous norepinephrine , 2002, The European journal of neuroscience.
[13] D. Weinshenker,et al. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. , 2002, Pharmacology & therapeutics.
[14] A. Kanner,et al. Depression and epilepsy: How closely related are they? , 2002, Neurology.
[15] Kazuto Kobayashi,et al. Genetic evidence for noradrenergic control of long-term memory consolidation , 2001, Brain and Development.
[16] Kazuto Kobayashi,et al. The Central Noradrenaline System and Memory Consolidation , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[17] J. Wheless,et al. Vagus Nerve Stimulation in Children with Refractory Seizures Associated with Lennox–Gastaut Syndrome , 2001, Epilepsia.
[18] D. Labar,et al. Vagus Nerve Stimulation: Analysis of Device Parameters in 154 Patients during the Long‐Term XE5 Study , 2001, Epilepsia.
[19] S. Pacia,et al. Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry , 2001, Brain Research.
[20] Kevin S. Chen,et al. Biochemical effects of the monoamine neurotoxins DSP‐4 and MDMA in specific brain regions of MAO‐B‐deficient mice , 2001, Synapse.
[21] G. Tononi,et al. Differential Expression of Plasticity-Related Genes in Waking and Sleep and Their Regulation by the Noradrenergic System , 2000, The Journal of Neuroscience.
[22] Scott Sands,et al. Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: Multiple system atrophy , 2000, Nature Medicine.
[23] J. Hohmann,et al. Pediatrics, and , 2022 .
[24] F. Fornai,et al. The role of the locus coeruleus in the development of Parkinson's disease , 2000, Neuroscience & Biobehavioral Reviews.
[25] F. Fornai,et al. Similar increases in extracellular lactic acid in the limbic system during epileptic and/or olfactory stimulation , 2000, Neuroscience.
[26] Mustafa M. Husain,et al. Vagus nerve stimulation: a new tool for brain research and therapy∗ , 2000, Biological Psychiatry.
[27] Nicole C. Rust,et al. Norepinephrine-Deficient Mice Have Increased Susceptibility to Seizure-Inducing Stimuli , 1999, The Journal of Neuroscience.
[28] F. Fornai,et al. Cholinergic and noradrenergic afferents influence the functional properties of the postnatal visual cortex in rats , 1999, Visual Neuroscience.
[29] K. Gale,et al. Regulation of Limbic Motor Seizures by GABA and Glutamate Transmission in Nucleus Tractus Solitarius , 1999, Epilepsia.
[30] M. Vergnes,et al. Spatial and Temporal Relationships between C-Fos Expression and Kindling of Audiogenic Seizures in Wistar Rats , 1999, Experimental Neurology.
[31] D. Woldbye. Antiepileptic effects of NPY on pentylenetetrazole seizures , 1998, Regulatory Peptides.
[32] Y. Kawaguchi,et al. Noradrenergic Excitation and Inhibition of GABAergic Cell Types in Rat Frontal Cortex , 1998, The Journal of Neuroscience.
[33] S. Krahl,et al. Locus Coeruleus Lesions Suppress the Seizure‐Attenuating Effects of Vagus Nerve Stimulation , 1998, Epilepsia.
[34] S. Stanford,et al. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo , 1998, Psychopharmacology.
[35] J. McNamara,et al. A Point Mutation (D79N) of the α2A Adrenergic Receptor Abolishes the Antiepileptogenic Action of Endogenous Norepinephrine , 1998, The Journal of Neuroscience.
[36] P. Jobe,et al. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study , 1998, Brain Research.
[37] E. J. Simon,et al. Activation of fos in mouse amygdala by local infusion of norepinephrine or atipamezole , 1997, Brain Research.
[38] P. J. Larsen,et al. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors , 1997, Nature Medicine.
[39] M. Proctor,et al. The role of nitric oxide in focally-evoked limbic seizures , 1997, Neuroscience.
[40] G Tononi,et al. Neuronal Gene Expression in the Waking State: A Role for the Locus Coeruleus , 1996, Science.
[41] Richard Hawkes,et al. Absence Epilepsy in Tottering Mutant Mice Is Associated with Calcium Channel Defects , 1996, Cell.
[42] J W Dailey,et al. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. , 1996, Biochemical pharmacology.
[43] G. Corsini,et al. Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[44] R. Szymusiak,et al. The α2 adrenoreceptor agonist clonidine suppresses seizures, whereas the α2 adrenoreceptor antagonist idazoxan promotes seizures: Pontine microinfusion studies of amygdala-kindled kittens , 1996, Brain Research.
[45] R. Palmiter,et al. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.
[46] J. Harro,et al. Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation , 1995, European Neuropsychopharmacology.
[47] E. Favale,et al. Anticonvulsant effect of fluoxetine in humans , 1995, Neurology.
[48] D. Naritoku,et al. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve , 1995, Epilepsy Research.
[49] K. Ilett,et al. Antidepressant Toxicity and the Need for Identification and Concentration Monitoring in Overdose , 1995, Clinical pharmacokinetics.
[50] M. Culic,et al. Effect of neurotoxin DSP4 on EEG power spectra in the rat acute model of epilepsy , 1995, Neuroscience Letters.
[51] M. Subhash,et al. Effect of chronic administration of phenytoin on regional monoamine levels in rat brain , 1995, Neurochemical Research.
[52] R. Palmiter,et al. Noradrenaline is essential for mouse fetal development , 1995, Nature.
[53] A. Gundlach,et al. Noradrenergic regulation of immediate early gene expression in rat forebrain: differential effects of αl- and α2-adrenoceptor drugs , 1995 .
[54] F. Bloom,et al. Psychopharmacology: The Fourth Generation of Progress , 1995 .
[55] M. Sabatino,et al. Locus coeruleus noradrenaline system and focal penicillin hippocampal epilepsy: Neurophysiological study , 1994, Epilepsy Research.
[56] A. Björklund,et al. Seizure Development and Noradrenaline Release in Kindling Epilepsy after Noradrenergic Reinnervation of the Subcortically Deafferented Hippocampus by Superior Cervical Ganglion or Fetal Locus Coeruleus Grafts , 1994, Experimental Neurology.
[57] L. Limbird,et al. Mutation of an aspartate residue highly conserved among G-protein-coupled receptors results in nonreciprocal disruption of alpha 2-adrenergic receptor-G-protein interactions. A negative charge at amino acid residue 79 forecasts alpha 2A-adrenergic receptor sensitivity to allosteric modulation by mon , 1994, The Journal of biological chemistry.
[58] T. Ogawa,et al. Regulation of basal release of GABA by noradrenaline in the kitten visual cortex , 1994, Neuroreport.
[59] M. Subhash,et al. Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine , 1994, Neurochemical Research.
[60] G. Aston-Jones,et al. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[61] M. Proctor,et al. Focal intracerebral elevation of L-lactate is anticonvulsant. , 1994, European journal of pharmacology.
[62] M. Subhash,et al. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain , 1994, Neurochemistry International.
[63] R. Browning,et al. Role of Norepinephrine in Forebrain and Brainstem Seizures: Chemical Lesioning of Locus Ceruleus with DSP4 , 1994, Experimental Neurology.
[64] T B Kuo,et al. Power spectral analysis of electroencephalographic desynchronization induced by cocaine in rats: Correlation with microdialysis evaluation of dopaminergic neurotransmission at the medial prefrontal cortex , 1994, Synapse.
[65] A. Björklund,et al. Characterization of in Vivo Noradrenaline Release from Superior Cervical Ganglia or Fetal Locus Coeruleus Transplanted to the Subcortically Deafferented Hippocampus in the Rat , 1993, Experimental Neurology.
[66] O. Lindvall,et al. Specific Functions of Grafted Locus Coeruleus Neurons in the Kindling Model of Epilepsy , 1993, Experimental Neurology.
[67] P. Jobe,et al. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis , 1993, Brain Research.
[68] M. Roisin,et al. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. , 1993, European journal of pharmacology.
[69] Y. Zhang,et al. Effect of locus coeruleus lesion on c-fos expression in the cerebral cortex caused by yohimbine injection or stress , 1993, Brain Research.
[70] Wade K. Smith,et al. Disease‐specific patterns of locus coeruleus cell loss , 1992, Annals of neurology.
[71] G. Telegdy,et al. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats , 1992, Brain Research.
[72] T. Itoh,et al. Presynaptic inhibition by clonidine of neurotransmitter amino acid release in various brain regions. , 1992, European journal of pharmacology.
[73] Leander Jd. Fluoxetine, a selective serotonin-uptake inhibitor, enhances the anticonvulsant effects of phenytoin, carbamazepine, and ameltolide (LY201116). , 1992 .
[74] K. Gale,et al. Subcortical structures and pathways involved in convulsive seizure generation. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[75] G. Bing,et al. C-Fos response to administration of catecholamines into brain by microdialysis , 1991, Neuroscience Letters.
[76] G. Bing,et al. Noradrenergic activation of immediate early genes in rat cerebral cortex. , 1991, Brain research. Molecular brain research.
[77] J. Noebels,et al. Synchronous hippocampal bursting reveals network excitability defects in an epilepsy gene mutation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[78] J. Penny,et al. Noradrenergic Abnormalities in the Central Nervous System of Seizure‐Naive Genetically Epilepsy‐Prone Rats , 1991, Epilepsia.
[79] F. Gonon,et al. An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. , 1991, The Journal of pharmacology and experimental therapeutics.
[80] J. L. Stringer,et al. Cholinergic and adrenergic agents modify the initiation and termination of epileptic discharges in the dentate gyrus , 1991, Neuropharmacology.
[81] D. Woodbury,et al. Vagal Stimulation Reduces the Severity of Maximal Electroshock Seizures in Intact Rats: Use of a Cuff Electrode for Stimulating and Recording , 1991, Pacing and clinical electrophysiology : PACE.
[82] A. Björklund,et al. Formation of synaptic graft-host connections by noradrenergic locus coeruleus neurons transplanted into the adult rat hippocampus , 1990, Experimental Neurology.
[83] J. Partanen,et al. The effects of concurrent manipulations of cholinergic and noradrenergic systems on neocortical EEG and spatial learning. , 1990, Behavioral and neural biology.
[84] B. Flumerfelt,et al. Efferent connections of the A1 noradrenergic cell group: A DBH immunohistochemical and PHA-L anterograde tracing study , 1990, Experimental Neurology.
[85] P. Rutecki,et al. Altered hippocampal network excitability in the hypernoradrenergic mutant mousetottering , 1990, Brain Research.
[86] P. Rutecki,et al. Anatomical, Physiological, and Theoretical Basis for the Antiepileptic Effect of Vagus Nerve Stimulation , 1990, Epilepsia.
[87] R. Browning,et al. Electroshock- and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): differences in threshold and pattern , 1990, Epilepsy Research.
[88] M. E. Corcoran,et al. Antikindling effects of locus coeruleus stimulation: Mediation by ascending noradrenergic projections , 1990, Experimental Neurology.
[89] J. Fritschy,et al. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals , 1989, Neuroscience.
[90] C. Ribak,et al. Differences in dopamine β-hydroxylase immunoreactivity between the brains of genetically epilepsy-prone and Sprague-Dawley rats , 1989, Epilepsy Research.
[91] E. Abercrombie,et al. Partial injury to central noradrenergic neurons: reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[92] A. Björklund,et al. Grafts of fetal locus coeruleus neurons in rat amygdala-piriform cortex suppress seizure development in hippocampal kindling , 1989, Experimental Neurology.
[93] M. A. Ariano,et al. Are glial cells targets of the central noradrenergic system? A review of the evidence , 1989, Brain Research Reviews.
[94] V. Chan‐Palay,et al. Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression , 1989, The Journal of comparative neurology.
[95] T. Archer,et al. Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behavior and monoamine alterations at adult stage , 1989, Behavioural Brain Research.
[96] J. Fairhurst,et al. Adrenergic receptors mediate changes in c-fos mRNA levels in brain. , 1989, Brain research. Molecular brain research.
[97] R. Browning,et al. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy-prone rat. , 1989, The Journal of pharmacology and experimental therapeutics.
[98] P. Jobe,et al. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat , 1989, Epilepsy Research.
[99] J. E. Franck,et al. Developing Genetically Epilepsy‐Prone Rats Have an Abnormal Seizure Response to Flurothyl , 1989, Epilepsia.
[100] M. E. Corcoran. Characteristics of accelerated kindling after depletion of noradrenaline in adult rats , 1988, Neuropharmacology.
[101] O. Lindvall,et al. Facilitation of focal cobalt-induced epilepsy after lesions of the noradrenergic locus coeruleus system , 1988, Brain Research.
[102] D. Johnston,et al. Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus. , 1988, Journal of neurophysiology.
[103] D. Mcintyre,et al. Effect of clonidine on amygdala kindling in normal and 6-hydroxydopamine-pretreated rats , 1988, Experimental Neurology.
[104] A. Björklund,et al. Grafted noradrenergic neurons suppress seizure development in kindling-induced epilepsy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[105] A. Vezzani,et al. Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes. , 1987, European journal of pharmacology.
[106] J. McNamara,et al. Alpha-2 receptors mediate an endogenous noradrenergic suppression of kindling development. , 1987, The Journal of pharmacology and experimental therapeutics.
[107] C. Jiménez-Rivera,et al. Effect of locus ceruleus stimulation on the development of kindled seizures , 1987, Experimental Neurology.
[108] P. Jobe,et al. Indices of Noradrenergic Function in the Central Nervous System of Seizure‐Naive Genetically Epilepsy‐Prone Rats , 1986, Epilepsia.
[109] D. Benson,et al. Depression in epilepsy. Significance and phenomenology. , 1986, Archives of neurology.
[110] D. Savage,et al. Angular bundle kindling is accelerated in rats with a genetic predisposition to acoustic stimulus-induced seizures , 1986, Brain Research.
[111] R. Wong,et al. Cellular and synaptic properties of amygdala-kindled pyriform cortex in vitro. , 1986, Journal of neurophysiology.
[112] A. Olivier,et al. α‐1 Adrenoceptors are decreased in human epileptic foci , 1986, Annals of neurology.
[113] B. Jones,et al. The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat , 1985, The Journal of comparative neurology.
[114] K. Gale,et al. A crucial epileptogenic site in the deep prepiriform cortex , 1985, Nature.
[115] S. Stanford,et al. Down-regulation of α 2- and β-adrenoceptor binding sites in rat cortex caused by amygdalar kindling , 1985, Experimental Neurology.
[116] S. Waller,et al. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development , 1985, Pharmacology Biochemistry and Behavior.
[117] J. Growdon,et al. Differential effects of DSP-4 administration on regional brain norepinephrine turnover in rats. , 1985, Life sciences.
[118] J. Noebels,et al. A single gene error of noradrenergic axon growth synchronizes central neurones , 1984, Nature.
[119] S. Harik,et al. The protective influence of the locus ceruleus on the blood‐brain barrier , 1984, Annals of neurology.
[120] M. Kuhar,et al. Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents , 1984, Brain Research Reviews.
[121] P. Jobe,et al. Evaluation of monoaminergic receptors in the genetically epilepsy prone rat , 1984, Experientia.
[122] P. Jobe,et al. Abnormalities in norepinephrine turnover rate in the central nervous system of the genetically epilepsy-prone rat , 1984, Brain Research.
[123] C. Harley,et al. Long-lasting potentiation of the dentate gyrus population spike by norepinephrine , 1983, Brain Research.
[124] R. S. Jones,et al. The action of anticonvulsant drugs on the firing of locus coeruleus neurons: selective, activating effect of carbamazepine. , 1983, European journal of pharmacology.
[125] F. Bloom,et al. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. , 1983, Physiological reviews.
[126] F. Gage,et al. Local regulation of compensatory noradrenergic hyperactivity in the partially denervated hippocampus , 1983, Nature.
[127] I. Altman,et al. Facilitation of neocortical kindling by depletion of forebrain noradrenaline , 1983, Brain Research.
[128] D. Mcintyre,et al. Differental effect of acute vs chronic desmethylimipramine on the rate of amygdala kindling in rats , 1982, Experimental Neurology.
[129] C. Köhler,et al. On the role of the dorsal mesencephalic tegmentum in the control of masculine sexual behavior in the rat: Effects of electrolytic lesions, ibotenic acid and DSP4 , 1982, Brain Research.
[130] Peter Room,et al. Divergent axon collaterals of rat locu Demonstration by a fluorescent double labeling technique , 1981, Brain Research.
[131] F. Bloom,et al. Nonrepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[132] F. Bloom,et al. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[133] P. Levitt,et al. Mutant mouse tottering: selective increase of locus ceruleus axons in a defined single-locus mutation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[134] G. Jonsson,et al. DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)--a useful denervation tool for central and peripheral noradrenaline neurons. , 1981, European journal of pharmacology.
[135] K. Satoh,et al. Divergent projections of catecholamine neurons of the locus coeruleus as revealed by fluorescent retrograde double labeling technique , 1981, Neuroscience Letters.
[136] D. Mcintyre. Amygdala kindling in rats: Facilitation after local amygdala norepinephrine depletion with 6-hydroxydopamine , 1980, Experimental Neurology.
[137] S. T. Mason,et al. Role of forebrain catecholamines in amygdaloid kindling , 1980, Brain Research.
[138] R. Gross,et al. Effects of reserpine, propranolol, and aminophylline on seizure activity and CNS cyclic nucleotides , 1979, Annals of neurology.
[139] A. Picchioni,et al. Audiogenic seizure susceptible rats. , 1979, Federation proceedings.
[140] S. T. Mason,et al. Catecholamines and convulsions , 1979, Brain Research.
[141] B. Pappas,et al. Potentiation of amygdala kindling in adult or infant rats by injections of 6-hydroxydopamine , 1979, Experimental Neurology.
[142] R. Oishi,et al. Possible involvement of brainstem norepinephrine in pentylenetetrazol convulsions in rats , 1979, Pharmacology Biochemistry and Behavior.
[143] J. Dymecki,et al. Audiogenic seizures in rats: relation to noradrenergic neurons of the locus coeruleus. , 1978, Acta physiologica Polonica.
[144] J. Fallon,et al. Catecholamine innervation of the basal forebrain III. Olfactory bulb, anterior olfactory nuclei, olfactory tubercle and piriform cortex , 1978, The Journal of comparative neurology.
[145] B. Libet,et al. Suppression of an Epileptiform Type of Electrocortical Activity in the Rat by Stimulation in the Vicinity of Locus Coeruleus , 1977, Epilepsia.
[146] D. G. Ward,et al. Locus coeruleus complex: elicitation of a pressor response and a brain stem region necessary for its occurence , 1976, Brain Research.
[147] Floyd E. Bloom,et al. The Biochemical Basis of Neuropharmacology , 1978 .
[148] B. R. Madan,et al. Anticonvulsant activity of some β-adrenoceptor blocking agents in mice , 1974 .
[149] P. Lidbrink,et al. NORADRENALINE NERVE TERMINALS IN THE CEREBRAL CORTEX: EFFECTS ON NORADRENALINE UPTAKE AND STORAGE FOLLOWING AXONAL LESION WITH 6‐HYDROXYDOPAMINE , 1974, Journal of neurochemistry.
[150] R. Racine,et al. Effects of atropine, reserpine, 6-hydroxydopamine, and handling on seizure development in the rat. , 1973, Experimental neurology.
[151] R. Racine,et al. Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.
[152] M. Jouvet,et al. Biogenic amines and the states of sleep. , 1969, Science.
[153] W. Murmann,et al. Central nervous system effects of four β‐adrenergic receptor blocking agents , 1966 .
[154] G GOERANSSON,et al. THE METABOLISM OF FATTY ACIDS IN THE RAT. VI. ARACHIDONIC ACID. , 1965, Acta physiologica Scandinavica.
[155] K. Fuxe,et al. Evidence for the existence of monoamine neurons in the central nervous system , 1965, Zeitschrift für Zellforschung und Mikroskopische Anatomie.
[156] K. Johansen. REGIONAL DISTRIBUTION OF CIRCULATING BLOOD DURING SUBMERSION ASPHYXIA IN THE DUCK. , 1964, Acta physiologica Scandinavica.
[157] Richard L. Sidman,et al. Tottering- a neuromuscular mutation in the mouse and its linkage with oligosyndactylism. , 1962 .
[158] G. Chen,et al. A Facilitation Action of Reserpine on the Central Nervous System , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[159] A. Brodal,et al. Neurological Anatomy in Relation to Clinical Medicine , 1950 .
[160] T. Archer,et al. DSP4-induced two-way active avoidance impairment in rats: Involvement of central and not peripheral noradrenaline depletion , 2004, Psychopharmacology.
[161] C. Degiorgio. Surgical anatomy, implantation technique, and operative complications , 2001 .
[162] D. Morilak,et al. Changes in Tyrosine Hydroxylase mRNA Expression in the Rat Locus Coeruleus Following Acute or Chronic Treatment with Valproic Acid , 2000, Neuropsychopharmacology.
[163] J. Wernicke,et al. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. , 1999, Critical reviews in neurobiology.
[164] Mark S. Seidenberg,et al. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. , 1999, Neurology.
[165] Dean K. Naritoku,et al. Enhanced recognition memory following vagus nerve stimulation in human subjects , 1999, Nature Neuroscience.
[166] T. Dunwiddie,et al. Adenosine and suppression of seizures. , 1999, Advances in neurology.
[167] S. Dunnett,et al. 6-Hydroxydopamine Lesions of Nigrostriatal Neurons as an Animal Model of Parkinson’s Disease , 1994 .
[168] P. Jobe,et al. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s). , 1993, Life sciences.
[169] P. Jobe,et al. Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats. , 1992, Life sciences.
[170] N. Ludvig,et al. Scope and contribution of genetic models to an understanding of the epilepsies. , 1991, Critical reviews in neurobiology.
[171] G. Aston-Jones,et al. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. , 1991, Progress in brain research.
[172] D. Kendall,et al. The influence of adrenalectomy on α-adrenoceptor responses in rat cerebral cortex slices , 1990 .
[173] D. Chadwick. The epidemiology of drug resistant epilepsy and adverse effects of antiepileptic drugs. , 1990, Acta neurochirurgica. Supplementum.
[174] C. Faingold. The genetically epilepsy-prone rat. , 1988, General pharmacology.
[175] G. Paxinos. The Rat nervous system , 1985 .
[176] J. Voogd,et al. The human central nervous system : a synopsis and atlas , 1978 .
[177] A. Picchioni,et al. Role of brain norepinephrine in audiogenic seizure in the rat. , 1973, The Journal of pharmacology and experimental therapeutics.
[178] K. Fuxe,et al. EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.
[179] Russell Gv. The nucleus locus coeruleus (dorsolateralis tegmenti). , 1955, Texas reports on biology and medicine.